{"id":"placebo-first-ba","safety":{"commonSideEffects":[]},"_chembl":null,"_dailymed":null,"mechanism":{"_ai_source":"claude-haiku-4.5","explanation":"This is a clinical trial methodology rather than a drug with a pharmacological mechanism. 'Placebo first BA' refers to a study design where subjects receive placebo in an initial period before crossing over to receive the active pharmaceutical agent, allowing researchers to measure the drug's bioavailability and pharmacokinetic properties while controlling for baseline variability.","oneSentence":"Placebo first BA is a bioavailability study design approach that administers placebo prior to the active drug to establish baseline pharmacokinetic parameters.","_ai_confidence":"low"},"_scrapedAt":"2026-03-28T00:00:46.793Z","_scrapedBy":"cloudflare-swarm","_wikipedia":null,"indications":{"approved":[]},"trialDetails":[{"nctId":"NCT07440147","phase":"NA","title":"Effects of Akkermansia Muciniphila and Berberine Supplementation on Insulin Sensitivity in Night-shift Workers","status":"RECRUITING","sponsor":"FH Joanneum Gesellschaft mbH","startDate":"2026-01-20","conditions":"Obesity & Overweight, Circadian Rhythm Disorders, Gut Microbiota Modulation","enrollment":200},{"nctId":"NCT03257319","phase":"PHASE3","title":"Inhaled vs IV Opioid Dosing for the Initial Treatment of Severe Acute Pain in the Emergency Department","status":"COMPLETED","sponsor":"University Hospital, Rouen","startDate":"2017-09-19","conditions":"Pain, Acute, Emergencies, Morphine","enrollment":226},{"nctId":"NCT04323189","phase":"PHASE4","title":"Effects of Sitagliptin in Individuals With Genetically Decreased DPP4","status":"ACTIVE_NOT_RECRUITING","sponsor":"University of Pennsylvania","startDate":"2020-08-26","conditions":"Genetics Disease, Type2 Diabetes, Heart Failure","enrollment":20},{"nctId":"NCT05488431","phase":"PHASE2","title":"Cholesterol and Inflammation Lowering Via Bempedoic Acid, an ACL-inhibiting Regimen in HIV Trial (CLEAR HIV Trial)","status":"RECRUITING","sponsor":"Priscilla Hsue, MD","startDate":"2023-03-01","conditions":"Dyslipidemias, Cardiovascular Diseases, HIV Infections","enrollment":121},{"nctId":"NCT07095049","phase":"PHASE1","title":"Safety, Tolerability, and Systemic Exposure of Apo-Si- K170A-C76 in Healthy Volunteers","status":"ACTIVE_NOT_RECRUITING","sponsor":"Interna Therapeutics Ltd.","startDate":"2024-09-04","conditions":"SARS-CoV-2 (COVID-19) Infection","enrollment":56},{"nctId":"NCT07092930","phase":"PHASE3","title":"Effects of β-alanine and Sodium Bicarbonate Supplementation on Physical Capacity and Biochemical Markers Concentrations","status":"RECRUITING","sponsor":"Poznan University of Physical Education","startDate":"2023-10-01","conditions":"Supplementation, Sports, Female Athletes","enrollment":100},{"nctId":"NCT03356639","phase":"PHASE1","title":"A Study to Assess the Safety, Tolerability, Pharmacodynamics and Pharmacokinetics of ASP6981 in Subjects With Schizophrenia","status":"COMPLETED","sponsor":"Astellas Pharma Global Development, Inc.","startDate":"2018-01-22","conditions":"Schizophrenia","enrollment":32},{"nctId":"NCT03797560","phase":"NA","title":"Comparison of Ba-Duan-Jin and Pregabalin in Patients with Fibromyalgia","status":"COMPLETED","sponsor":"Guang'anmen Hospital of China Academy of Chinese Medical Sciences","startDate":"2019-03-22","conditions":"Fibromyalgia","enrollment":104},{"nctId":"NCT03890133","phase":"NA","title":"Exploration the Mechanism of Ba-Duan-Jin Therapy in the Management of Fibromyalgia","status":"COMPLETED","sponsor":"Guang'anmen Hospital of China Academy of Chinese Medical Sciences","startDate":"2019-04-01","conditions":"Fibromyalgia","enrollment":60},{"nctId":"NCT04223960","phase":"PHASE1","title":"A Study to Evaluate the Safety, Tolerability, Pharmacokinetics, Pharmacodynamics, Bioavailability, and Food-effects of EA1080 in Healthy Caucasian and Japanese Male Participants","status":"COMPLETED","sponsor":"EA Pharma Co., Ltd.","startDate":"2020-01-09","conditions":"Healthy Volunteers","enrollment":184},{"nctId":"NCT03055767","phase":"PHASE2","title":"Effectiveness of Onabotulinumtoxin A (Botox) in Pediatric Patients Experiencing Migraines: A Study in the Pediatric Pain Population","status":"COMPLETED","sponsor":"University of California, Irvine","startDate":"2017-03-01","conditions":"Migraine Disorders, Headache, Migraine, Pediatrics","enrollment":17},{"nctId":"NCT04977479","phase":"PHASE2","title":"The Safety of Administering a Second Dose of a COVID-19 mRNA Vaccine in Individuals Who Experienced a Systemic Allergic Reaction to an Initial Dose","status":"COMPLETED","sponsor":"National Institute of Allergy and Infectious Diseases (NIAID)","startDate":"2021-09-08","conditions":"Systemic Allergic Reaction","enrollment":20},{"nctId":"NCT03004404","phase":"PHASE1","title":"To Assess Safety, Tolerability and Pharmacokinetics of BI 730357 in Healthy Male Volunteers","status":"COMPLETED","sponsor":"Boehringer Ingelheim","startDate":"2017-01-12","conditions":"Healthy Volunteers","enrollment":84},{"nctId":"NCT02991859","phase":"PHASE2","title":"Phase 2a, AMP Challenge, Dose Escalation Study to Assess the Dose Response for Topical Efficacy and Systemic Activity in Asthmatic Subjects","status":"COMPLETED","sponsor":"GlaxoSmithKline","startDate":"2017-02-09","conditions":"Asthma","enrollment":56},{"nctId":"NCT02397356","phase":"PHASE4","title":"Inhaled Nebulised S(+)-Ketamine for Postoperative Analgesia","status":"WITHDRAWN","sponsor":"Tampere University Hospital","startDate":"2018-08","conditions":"Pain, Postoperative","enrollment":""},{"nctId":"NCT00756275","phase":"NA","title":"Varenicline and Motivational Advice for Smokers With Substance Use Disorders","status":"COMPLETED","sponsor":"Brown University","startDate":"2009-01","conditions":"Smoking Cessation, Nicotine Dependence","enrollment":158},{"nctId":"NCT00500201","phase":"PHASE1","title":"A Healthy Volunteer Study to Assess the Relative Bioavailability of 2 Forms of SB773812 Tablets.","status":"COMPLETED","sponsor":"GlaxoSmithKline","startDate":"2007-05-24","conditions":"Schizophrenia","enrollment":18},{"nctId":"NCT01792271","phase":"NA","title":"Sustained Effects of Hypertonic Saline on Mucociliary Clearance in Subjects With Chronic Bronchitis","status":"COMPLETED","sponsor":"University of North Carolina, Chapel Hill","startDate":"2013-02","conditions":"Chronic Obstructive Pulmonary Disease, COPD, Chronic Bronchitis","enrollment":25},{"nctId":"NCT02807675","phase":"PHASE1","title":"A Study of the Safety and Tolerability of a Single Dose Administration of CVT-301 (Levodopa Inhalation Powder)","status":"COMPLETED","sponsor":"Acorda Therapeutics","startDate":"2016-06","conditions":"Parkinson's Disease","enrollment":36},{"nctId":"NCT02633007","phase":"PHASE1","title":"A Study of the Safety and Pharmacokinetics of Levodopa Following Administration of CVT 301 (Levodopa Inhalation Powder) in Adults With Asthma","status":"COMPLETED","sponsor":"Acorda Therapeutics","startDate":"2015-12","conditions":"Asthma","enrollment":25},{"nctId":"NCT00769015","phase":"PHASE3","title":"Low Vision Depression Prevention Trial for Age Related Macular Degeneration","status":"COMPLETED","sponsor":"Thomas Jefferson University","startDate":"2009-06","conditions":"Age-related Macular Degeneration, Depression","enrollment":188},{"nctId":"NCT00895102","phase":"PHASE1","title":"Bioavailability of ABT-333 Tablet Versus First in Human (FIH) Capsule Formulation and Safety, Tolerability and PK Study of Single Doses of ABT-333 in Healthy Volunteers","status":"COMPLETED","sponsor":"Abbott","startDate":"2009-04","conditions":"HCV Infection","enrollment":34}],"_emaApprovals":[],"_faersSignals":[],"_approvalHistory":[],"publicationCount":1,"rwe":[],"genericFilers":[],"relatedDrugs":[],"labelChanges":[],"biosimilarFilings":[],"pricing":[],"formularyStatus":[],"manufacturing":[],"companionDiagnostics":[],"competitors":[],"timeline":[],"patents":[],"ownershipHistory":[],"trials":[],"biosimilars":[],"latestUpdates":[],"references":[],"tags":[],"ecosystem":[],"genericManufacturerList":[],"offLabel":[],"developmentCodes":[],"aliases":["NaCl","Saline"],"phase":"marketed","status":"active","brandName":"Placebo first BA","genericName":"Placebo first BA","companyName":"Tampere University Hospital","companyId":"tampere-university-hospital","modality":"Small molecule","firstApprovalDate":"","aiSummary":"","enrichmentLevel":3,"visitCount":0,"trialStats":{"total":0,"withResults":0},"verificationStatus":"partial","dataCompleteness":{"mechanism":true,"indications":false,"safety":false,"trials":true,"score":2}}